International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 1 , Pages 269-276 , 1 May 2010

A Novel Dose Constraint to Reduce Xerostomia in Head-and-Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy

  • Lidia Strigari, Ph.D.

      Affiliations

    • Laboratory of Medical Physics and Expert Systems, Regina Elena National Cancer Institute, Rome, Italy
    • Corresponding Author InformationReprint requests to: Lidia Strigari, Ph.D., Laboratory of Medical Physics and Expert Systems, Regina Elena National Cancer Institute, via E. Chianesi 53, 00144 Rome, Italy. Tel: (+39) 6-52665602; Fax: (+39) 6-52662740
    • ,
  • Marcello Benassi, Ph.D.

      Affiliations

    • Laboratory of Medical Physics and Expert Systems, Regina Elena National Cancer Institute, Rome, Italy
    • ,
  • Giorgio Arcangeli, M.D.

      Affiliations

    • Laboratory of Medical Physics and Expert Systems, Regina Elena National Cancer Institute, Rome, Italy
    • ,
  • Vicente Bruzzaniti, Ph.D.

      Affiliations

    • Laboratory of Medical Physics and Expert Systems, Regina Elena National Cancer Institute, Rome, Italy
    • ,
  • Giuseppe Giovinazzo, M.D.

      Affiliations

    • Department of Radiotherapy, Regina Elena National Cancer Institute, Rome, Italy
    • ,
  • Laura Marucci, M.D.

      Affiliations

    • Department of Radiotherapy, Regina Elena National Cancer Institute, Rome, Italy

Received 25 November 2008 ,Revised 25 July 2009 ,Accepted 29 July 2009.

References 

  1. Boyer AL, Geis P, Grant W, et al. Modulated beam conformal therapy for head and neck tumors. Int J Radiat Oncol Biol Phys. 1997;39:227–236
  2. De Neve W, De Gersem W, Derycke S, et al. Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic control. Radiother Oncol. 1999;50:301–314
  3. Eisbruch A, Marsh LH, Martel MK, et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: Assessment of target coverage and non-involved tissue sparing. Int J Radiat Oncol Biol Phys. 1998;41:559–568
  4. Sultanem K, Shu HK, Xia P, et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2000;48:711–722
  5. Van Dieren EB, Nowak PJCM, Wijers OB, et al. Beam intensity modulation using tissue compensators or dynamic multileaf collimation in three-dimensional conformal radiotherapy in cancer of the oropharynx and larynx, including the elective neck. Int J Radiat Oncol Biol Phys. 2000;47:1299–1309
  6. Verellen D, Linthout N, van den Berge D, et al. Initial experience with intensity-modulated conformal radiation therapy for treatment of the head and neck region. Int J Radiat Oncol Biol Phys. 1997;39:99–114
  7. Wu Q, Manning M, Schmidt-Ullrich R, et al. The potential for sparing of parotids and escalation of biologically effective dose with intensity modulated radiation treatments of head and neck cancer: A treatment design study. Int J Radiat Oncol Biol Phys. 2000;46:195–205
  8. Lee AW, Sze WM, Au JS, et al. Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005;61:1107–1116
  9. Chao KS, Wippold FJ, Ozyigit G, et al. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys. 2002;53:1174–1184
  10. Marks JE, Davis CC, Gottsman VL, et al. The effects of radiation of parotid salivary function. Int J Radiat Oncol Biol Phys. 1981;7:1013–1019
  11. Leslie MD, Dische S. The early changes in salivary gland function during and after radiotherapy given for head and neck cancer. Radiother Oncol. 1994;30:26–32
  12. Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys. 2001;49:907–916
  13. Eisbruch A, Ten Haken RK, et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577–587
  14. Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors following parotid-sparing irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:695–704
  15. Murdoch-Kinch CA, Kim HM, Vineberg KA, et al. Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72:373–382
  16. Edgar WM. Saliva and dental health. Clinical implications of saliva: Report of a consensus meeting. Br Dent J. 1990;169:96–98
  17. In:  Roth G,  Calmes R editor. Salivary glands and saliva. In: Oral biology. St Louis: CV Mosby; 1981;p. 196–236
  18. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346
  19. Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: A follow up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys. 1994;28:847–856
  20. Harrison LB, Zelefski MJ, Pfitzer DG, et al. Detailed quality of life assessment in patients with primary radiotherapy for cancer of the base of tongue. Head Neck. 1997;19:169–175
  21. Meirovitz A, Murdoch-Kinch CA, Scipper M, et al. Grading xerostomia by physicians or by patients after IMRT. Int J Radiat Oncol Biol Phys. 2006;66:445–453
  22. Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after intensity modulated or conventional radiotherapy: Randomized study. Int J Radiat Oncol Biol Phys. 2006;66:981–991
  23. Blanco AI, Chao KSC, El Naqa I, et al. Dose-volume modelling of salivary function in patients with head and neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:1055–1069
  24. Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine in head and neck cancer. J Clin Oncol. 2000;18:3339–3345
  25. Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health-related quality of life and salivary flow rates after IMRT. Int J Radiat Oncol Biol Phys. 2004;58:663–673
  26. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc. 1987;115:581–584
  27. Franzen L, Funegard U, Ericson T, et al. Parotid gland function during and following radiotherapy. Eur J Cancer. 1992;28:457–462
  28. Atkinson JC, Fox PC. Salivary gland disfunction. Clin Geriatr Med. 1992;8:499–511
  29. Strigari L, D'Andrea M, Abate A, et al. A heterogeneous dose distribution in simultaneous integrated boost: The role of the clonogenic cell density on the tumor control probability. Phys Med Biol. 2008;53:5257–5273
  30. Amosson CM, Teh BS, Van TJ, et al. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. Int J Radiat Oncol Biol Phys. 2003;56:136–144
  31. R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2008;
  32. Peterson D, Sonis S. Oral complication of cancer chemotherapy. Dev Oncol. 1983;12:80–118
  33. Humphrey SP, Williamson RT. A review of saliva: Normal composition, flow, and function. J Prosthet Dent. 2001;85:162–169
  34. Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: A theoretical model. Soc Sci Med. 1999;48:1507–1515
  35. Lee EK, Fox T, Crocker I. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2006;64:301–320
  36. Astreinidou E, Dehnad H, Terhaard CHJ, et al. Level II lymph nodes and radiation-induced xerostomia. Int J Radiat Oncol Biol Phys. 2004;58:124–131
  37. Jellema AP, Doornaert P, Slotman BJ, et al. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?. Radiother Oncol. 2005;77:164–171
  38. Houweling AC, Dijkema T, Roesink JM, et al. Sparing the contralateral submandibular gland in oropharyngeal cancer patients: A planning study. Radiother Oncol. 2008;89:64–70
  39. Cox DR, Snell EJ. Analysis of binary data. New York: Chapman and Hall; 1989;p. 140

 Conflict of interest: none.

PII: S0360-3016(09)02948-4

doi: 10.1016/j.ijrobp.2009.07.1734

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 1 , Pages 269-276 , 1 May 2010

Article Tools

* Image Usage & Resolution